These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 25453353)
1. A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women. Spangler L; Ichikawa LE; Hubbard RA; Operskalski B; LaCroix AZ; Ott SM; Scholes D Ann Epidemiol; 2015 Jan; 25(1):55-9. PubMed ID: 25453353 [TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use: interview data versus pharmacy records. Norell SE; Boethius G; Persson I Int J Epidemiol; 1998 Dec; 27(6):1033-7. PubMed ID: 10024199 [TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and history of oral contraceptive use. Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923 [TBL] [Abstract][Full Text] [Related]
5. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Barad D; Kooperberg C; Wactawski-Wende J; Liu J; Hendrix SL; Watts NB Fertil Steril; 2005 Aug; 84(2):374-83. PubMed ID: 16084878 [TBL] [Abstract][Full Text] [Related]
6. Agreement between women's histories of oral contraceptive use and physician records. Rosenberg MJ; Layde PM; Ory HW; Strauss LT; Rooks JB; Rubin GL Int J Epidemiol; 1983 Mar; 12(1):84-7. PubMed ID: 6302013 [TBL] [Abstract][Full Text] [Related]
7. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women. Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT Menopause; 2008; 15(2):332-9. PubMed ID: 17667152 [TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584 [TBL] [Abstract][Full Text] [Related]
10. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Curtis JR; Westfall AO; Allison J; Freeman A; Kovac SH; Saag KG Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):710-8. PubMed ID: 16498575 [TBL] [Abstract][Full Text] [Related]
11. Association between past oral contraceptive use and the prevalence of hypertension in postmenopausal women: the fifth (2010-2012) Korea National Health and Nutrition Examination Survey (KNHANES V). Lee J; Jeong H; Yoon JH; Yim HW BMC Public Health; 2022 Jan; 22(1):27. PubMed ID: 34991554 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and the occurrence of pituitary prolactinoma. Shy KK; McTiernan AM; Daling JR; Weiss NS JAMA; 1983 Apr 22-29; 249(16):2204-7. PubMed ID: 6834618 [TBL] [Abstract][Full Text] [Related]
13. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women. Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211 [TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use in relation to smoking. Morabia A; Bernstein M; Bleed D; Campana A Acta Obstet Gynecol Scand; 1998 Feb; 77(2):205-9. PubMed ID: 9512329 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives for the prevention of osteoporosis. Corson SL J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. Rooks JB; Ory HW; Ishak KG; Strauss LT; Greenspan JR; Hill AP; Tyler CW JAMA; 1979 Aug; 242(7):644-8. PubMed ID: 221698 [TBL] [Abstract][Full Text] [Related]
17. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports. Hawley W; Nuovo J; DeNeef CP; Carter P J Am Board Fam Pract; 1993; 6(2):123-35. PubMed ID: 8452064 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Timur S; Sahin NH Menopause; 2010; 17(3):545-51. PubMed ID: 20400922 [TBL] [Abstract][Full Text] [Related]
19. Differential factors associated with hot flashes in Chinese perimenopausal and postmenopausal women. Zhang Q; Li F; Yu Y; Yu X; Sheng Q; Zhang X Maturitas; 2009 May; 63(1):94-8. PubMed ID: 19321276 [TBL] [Abstract][Full Text] [Related]
20. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P Obstet Gynecol; 1991 Aug; 78(2):161-70. PubMed ID: 2067757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]